JP2002501015A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002501015A5 JP2002501015A5 JP2000528271A JP2000528271A JP2002501015A5 JP 2002501015 A5 JP2002501015 A5 JP 2002501015A5 JP 2000528271 A JP2000528271 A JP 2000528271A JP 2000528271 A JP2000528271 A JP 2000528271A JP 2002501015 A5 JP2002501015 A5 JP 2002501015A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP1998/000345 WO1999037289A1 (en) | 1998-01-22 | 1998-01-22 | Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002501015A JP2002501015A (ja) | 2002-01-15 |
| JP2002501015A5 true JP2002501015A5 (https=) | 2005-12-22 |
Family
ID=8166843
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000528271A Pending JP2002501015A (ja) | 1998-01-22 | 1998-01-22 | リーシュマニア症の治療における経口投与のためのミルテフォシンを含有する固形医薬品 |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6544551B1 (https=) |
| EP (1) | EP1051159B1 (https=) |
| JP (1) | JP2002501015A (https=) |
| KR (1) | KR100517399B1 (https=) |
| CN (1) | CN100413492C (https=) |
| AT (1) | ATE215817T1 (https=) |
| AU (1) | AU756805B2 (https=) |
| BR (1) | BR9814772A (https=) |
| CA (1) | CA2318260C (https=) |
| CZ (1) | CZ299229B6 (https=) |
| DE (1) | DE69804865T2 (https=) |
| DK (1) | DK1051159T3 (https=) |
| ES (1) | ES2175663T3 (https=) |
| HU (1) | HUP0004363A3 (https=) |
| IL (1) | IL136196A (https=) |
| NO (1) | NO20003674D0 (https=) |
| NZ (1) | NZ505648A (https=) |
| PL (1) | PL189654B1 (https=) |
| PT (1) | PT1051159E (https=) |
| SI (1) | SI1051159T1 (https=) |
| SK (1) | SK284839B6 (https=) |
| TR (1) | TR200001717T2 (https=) |
| UA (1) | UA68372C2 (https=) |
| WO (1) | WO1999037289A1 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7887817B2 (en) * | 2002-01-25 | 2011-02-15 | Aeterna Zentaris Gmbh | Process for preventing protozoal diseases |
| DE10203195A1 (de) * | 2002-01-25 | 2003-08-07 | Zentaris Ag | Verwendung von Alkylphosphocholinen in der Präventivbehandlung von Protozoenerkrankungen |
| WO2003090757A1 (en) * | 2002-04-26 | 2003-11-06 | Rudolf Perl | Pharmaceutical compositions of phospholipid derivatives |
| JP2005535688A (ja) | 2002-07-30 | 2005-11-24 | ツェンタリス ゲゼルシャフト ミット ベシュレンクテル ハフツング | 抗腫瘍医薬との組合せにおけるアルキルホスホコリンの使用 |
| US8383605B2 (en) | 2002-07-30 | 2013-02-26 | Aeterna Zentaris Gmbh | Use of alkylphosphocholines in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals |
| CA2526586C (en) | 2003-09-09 | 2010-03-16 | Biogen International Gmbh | The use of fumaric acid derivatives for treating cardiac insufficiency, and asthma |
| PL2316430T3 (pl) | 2004-10-08 | 2012-11-30 | Forward Pharma As | Kompozycje farmaceutyczne o kontrolowanym uwalnianiu, zawierające ester kwasu fumarowego |
| US8703179B2 (en) | 2006-05-11 | 2014-04-22 | Kimberly-Clark Worldwide, Inc. | Mucosal formulation |
| WO2010020276A1 (en) * | 2008-08-19 | 2010-02-25 | Orphanidis Pharma Research Gmbh | Treatment of coccidian parasites |
| WO2011123691A1 (en) | 2010-03-31 | 2011-10-06 | Keryx Biopharmaceuticals, Inc. | Perifosine and capecitabine as a combined treatment for cancer |
| BR112013012652A2 (pt) | 2010-11-22 | 2016-09-06 | Dafra Pharma Res & Dev Bvba | forma de dosagem sólida de oleil fosfocolina para administração oral, forma de dosagem sólida, e método para a preparação de uma forma de dosagem sólida |
| AU2012272642B2 (en) | 2011-06-24 | 2017-09-07 | Gri Bio, Inc. | Prevention and treatment of inflammatory conditions |
| WO2014166941A1 (en) * | 2013-04-08 | 2014-10-16 | Academisch Medisch Centrum | Miltefosin or perifosin for use in the treatment of ibd |
| WO2016042372A1 (en) | 2014-09-17 | 2016-03-24 | Steer Engineering Private Limited | Effervescent composition and method of making it |
| CN104473941A (zh) * | 2014-12-20 | 2015-04-01 | 长沙佰顺生物科技有限公司 | 一种含有米替福新的药物制剂及其制备方法 |
| WO2017098481A1 (en) | 2015-12-12 | 2017-06-15 | Steerlife India Private Limited | Effervescent compositions of metformin and processes for preparation thereof |
| PL3965739T3 (pl) * | 2019-04-12 | 2025-01-13 | Oblita Therapeutics Bvba | Postacie dawkowane będące tabletkami oleilofosfocholiny |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE888444C (de) * | 1951-11-10 | 1953-08-31 | Benckiser Gmbh Joh A | Verfahren zum Tablettieren von hygroskopischen Praeparaten |
| IE59777B1 (en) * | 1985-12-04 | 1994-04-06 | Max Planck Gesellschaft | Medicaments |
| US4762658A (en) * | 1986-10-08 | 1988-08-09 | Central Soya Company, Inc. | Method of tableting of de-oiled phosphatides (lecithin) |
| EP0916343A1 (de) * | 1989-09-27 | 1999-05-19 | ASTA Medica Aktiengesellschaft | Verwendung von Alkylphosphorsäure-Verbindungen zur Bekämpfung von Psoriasis-Erkrankungen |
| US5290769A (en) * | 1989-09-27 | 1994-03-01 | Asta Pharma Aktiengesellschaft | Use of hexadecylphosphocholine for the treatment of psoriasis |
| DE4132344A1 (de) * | 1991-09-27 | 1993-04-01 | Max Planck Gesellschaft | Verfahren zur herstellung eines arzneimittels zur oralen oder topischen verabreichung bei der behandlung von leishmaniasis |
-
1998
- 1998-01-22 DK DK98904121T patent/DK1051159T3/da active
- 1998-01-22 SI SI9830205T patent/SI1051159T1/xx unknown
- 1998-01-22 IL IL13619698A patent/IL136196A/en not_active IP Right Cessation
- 1998-01-22 AU AU62121/98A patent/AU756805B2/en not_active Ceased
- 1998-01-22 KR KR10-2000-7008029A patent/KR100517399B1/ko not_active Expired - Fee Related
- 1998-01-22 PL PL98342838A patent/PL189654B1/pl not_active IP Right Cessation
- 1998-01-22 AT AT98904121T patent/ATE215817T1/de not_active IP Right Cessation
- 1998-01-22 HU HU0004363A patent/HUP0004363A3/hu unknown
- 1998-01-22 JP JP2000528271A patent/JP2002501015A/ja active Pending
- 1998-01-22 NZ NZ505648A patent/NZ505648A/xx unknown
- 1998-01-22 WO PCT/EP1998/000345 patent/WO1999037289A1/en not_active Ceased
- 1998-01-22 BR BR9814772-2A patent/BR9814772A/pt not_active Application Discontinuation
- 1998-01-22 SK SK986-2000A patent/SK284839B6/sk unknown
- 1998-01-22 EP EP98904121A patent/EP1051159B1/en not_active Expired - Lifetime
- 1998-01-22 DE DE69804865T patent/DE69804865T2/de not_active Expired - Lifetime
- 1998-01-22 CA CA002318260A patent/CA2318260C/en not_active Expired - Fee Related
- 1998-01-22 PT PT98904121T patent/PT1051159E/pt unknown
- 1998-01-22 UA UA2000084909A patent/UA68372C2/uk unknown
- 1998-01-22 CZ CZ20002596A patent/CZ299229B6/cs not_active IP Right Cessation
- 1998-01-22 TR TR2000/01717T patent/TR200001717T2/xx unknown
- 1998-01-22 CN CNB988125714A patent/CN100413492C/zh not_active Expired - Fee Related
- 1998-01-22 ES ES98904121T patent/ES2175663T3/es not_active Expired - Lifetime
-
2000
- 2000-07-18 NO NO20003674A patent/NO20003674D0/no not_active Application Discontinuation
- 2000-07-24 US US09/624,890 patent/US6544551B1/en not_active Expired - Lifetime